Company
Headquarters: Monza, MI, Italy
Employees: 4,786
CEO: Engineer Aldo Fumagalli Romario
€3.43 Billion
EUR as of Jan. 1, 2025
US$3.57 Billion
Company | Market Cap (USD) |
---|---|
Air Liquide SA | $97.26 B |
Air Products and Chemicals, Inc. | $72.05 B |
Shin-Etsu Chemical Co Ltd | $63.76 B |
Saudi Basic Industries Corp | $54.94 B |
BASF SE | $42.22 B |
Company | Market Cap (USD) |
---|---|
Linde | $209.90 B |
BHP | $151.21 B |
Rio Tinto | $102.04 B |
Air Liquide SA | $97.26 B |
The Sherwin-Williams Company | $90.95 B |
SOL S.p.A. engages in the applied research, production, and distribution of industrial, pure, and medicinal gases; and in door-to-door medical care and related medical equipment in Italy and internationally. It offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium, as well as synthetic and compressed air; gas for electronics; ammonia and combustible gases for industrial use; gases and gas mixtures for respiratory and therapeutic, and diagnostic and instrumental use; and special gases and gas mixtures. The company also provides services, apparatus, and products for home oxygen therapy, home mechanical ventilation, home artificial feeding, and home treatment of bed sores; home treatment services for nocturnal apnoea syndrome; and integrated homecare services. In addition, it produces hydroelectric power; and engages in the exploration and identification, design, construction, and running of hydroelectric power stations connected to the national high tension distribution network. Further, the company designs, constructs, and manages bio banks, cell factories, and centers for processing and conserving cells and tissues; offers pre-and post-natal diagnostic services; and produces and sells diagnostic systems and services. Additionally, it is involved in the GMP production of monoclonal antibodies and recombinant proteins; and scientific, pre-clinical, and clinical research of biological pharmaceuticals, as well as the provision of transport and biological sample conservation services for third parties. SOL S.p.A. products are used in the chemical, electronics, iron and steel, engineering, and foodstuff industries, as well as in environmental protection, and research and health sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Gas and Technologies World BV.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | June 30, 2024 |
Revenue TTM | €1.55 B |
EBITDA | €369.0 M |
Gross Profit TTM | €641.5 M |
Profit Margin | 9.10% |
Operating Margin | 13.28% |
Quarterly Revenue Growth | 6.70% |
SOL S.p.A. has the following listings and related stock indices.
Stock: MTA: SOL wb_incandescent
Stock: XSTU: QOL wb_incandescent